(Total Views: 628)
Posted On: 04/08/2021 2:54:31 AM
Post# of 148870
I liked this one from the cc
The mortality rate in the extension of CD12 right now in critically ill population is about 16.7%. About 17%. CD12 we had results of 28% in leronlimab, 37% in placebo
Read More: https://investorshangout.com/post/view?id=610...z6rQOIaqKU
The mortality rate in the extension of CD12 right now in critically ill population is about 16.7%. About 17%. CD12 we had results of 28% in leronlimab, 37% in placebo
Read More: https://investorshangout.com/post/view?id=610...z6rQOIaqKU
(6)
(0)
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
Scroll down for more posts ▼
